Hypertrophic Cardiomyopathy Video Series with Christine E. Seidman, MD, FACC, FAHA

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor Christine Book sat down with the cardiovascular research leader to learn more about the critical work and research she is conducting in this field.

In the first of this 3-part “One on One” series, Dr. Christine Seidman — recognized as one of the world’s most respected physician scientists — delves into the research and treatments of the heart muscle disorder, hypertrophic cardiomyopathy. Watch Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader

In part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based diagnostics at Harvard’s Seidman Lab which allowed for targeted disease treatment of hypertrophic cardiomyopathy. Watch Part 2: Hypertrophic Cardiomyopathy in Focus, here.

In the third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at Harvard’s Seidman Lab, and how she views the value of learning from and mentoring a new generation of researchers. Watch Part 3: Award-winning Researcher Shares Update on Hypertrophic Cardiomyopathy Work and Value of Mentoring

Related Hypertrophic Cardiomyopathy content:

Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader

Part 2: Hypertrophic Cardiomyopathy in Focus

Part 3: Award-winning Researcher Shares Update on Hypertrophic Cardiomyopathy Work and Value of Mentoring

Imbria Pharmaceuticals Completes Enrollment in the Phase 2 IMPROVE-ISCHEMIA Clinical Trial of Ninerafaxstat in Patients with Stable Angina

Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released

First International Guidelines on Heart Muscle Diseases Published